Archives of Virology

, Volume 141, Issue 3–4, pp 439–447 | Cite as

Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM10.1

  • K. Hashimoto
  • M. Baba
  • K. Gohnai
  • M. Sato
  • S. Shigeta
Original Papers


A long period of clinical latency before development of symptoms is characteristic of human immunodeficiency virus type 1 (HIV-1) infection. OM10.1, a promyelocyte cell line latently infected with HIV-1, has been developed as a model for studying the mechanism of viral latency and the activation of virus expression. We found that this latently infected cell line with heat shock at 42°C for 2 h resulted in a high level of HIV-1 production without addition of any cytokines. The mechanism of activation was analyzed by using anti-TNF-α antibody and various inhibitors. Although the TNF-α level in culture supernatants was below the sensitivity of an ELISA assay system, addition of anti-TNF-α antibody in culture medium could partially suppress the heat shock induced HIV-1 production. Staurosporine (PKC inhibitor), pentoxifylline (NF-ϰB inhibitor), and Ro5-3335 (HIV-1 Tat inhibitor) also inhibited significantly the heat shock induced virus activation. In particular, staurosporine achieved approximately 90% inhibition of the HIV-1 antigen expression in heat shock-treated OM10.1 at a non-toxic concentration. Although the mechanism of HIV-1 activation with heat shock has not been fully elucidated yet, it is presumed PKC plays an important role in HIV-1 activation. Thus, the present observations will provide a further insight into the pathogenesis of HIV-1 infections.


Human Immunodeficiency Virus Heat Shock Pentoxifylline Staurosporine Viral Latency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Biswas DK, Dezube BJ, Ahlers CM, and Pardee AB (1993) Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-κB action. J Acquir Immune Defic Syndr 6: 778–786PubMedGoogle Scholar
  2. 2.
    Brown FL, Tahaoglu E, Graham GJ, Maio JJ (1993) Inducible transcriptional activation of the human immunodeficiency virus long terminal repeat by protein kinase inhibitors. Mol Cell Biol 13: 5245–5254PubMedGoogle Scholar
  3. 3.
    Butera ST, Perez VL, Wu BY, Nabel GJ, Folks TM (1991) Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. J Virol 65: 4645–4653PubMedGoogle Scholar
  4. 4.
    Butera ST, Roberts BD, Lam L, Hodge T, Folks TM (1994) Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J Virol 68: 2726–2730PubMedGoogle Scholar
  5. 5.
    Clouse KA, Powell D, Washington I, Poli G, Strebel K, Farrar W, Barstad P, Kovacs J, Fauci AS, Folks TM (1989) Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 142: 431–438PubMedGoogle Scholar
  6. 6.
    Collins PL, Hightower LE (1982) Newcastle disease virus stimulates the cellular accumulation of stress (heat shock) mRNAs and proteins. J Virol 44: 703–707PubMedGoogle Scholar
  7. 7.
    Doppler C, Schalasta G, Amtmann E, Sauer G (1992) Binding of NF-κB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity. AIDS Res Hum Retroviruses 8: 245–252PubMedGoogle Scholar
  8. 8.
    Fauci AS (1993) Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262: 1011–1018PubMedGoogle Scholar
  9. 9.
    Feorino PM, Butera ST, Folks TM, Schinazi RF (1993) Prevention of activation of HIV-1 by antiviral agents in OM10.1 cells. Antiviral Chem Chemother 4: 55–63Google Scholar
  10. 10.
    Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS (1987) Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800–802PubMedGoogle Scholar
  11. 11.
    Folks TM, Justement J, Kinter A, Schnittman S, Orenstein J, Poli G, Fauci AS (1988) Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol 140: 1117–1122PubMedGoogle Scholar
  12. 12.
    Geelen JLMC, Boom R, Klaver GPM, Minnaar RP, Feltkamp MCW, Milligen FJV, Sol CJA, Noordaa JVD (1987) Transcriptional activation of the major immediate early transcription unit of human cytomegalovirus by heat-shock, arsenite and protein synthesis inhibitors. J Gen Virol 68: 2925–2931PubMedGoogle Scholar
  13. 13.
    Hashimoto K, Shigets S, Baba M (1995) Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes. J Acquir Immune Defic Syndr Hum Retroviruses 10: 393–399Google Scholar
  14. 14.
    Hsu MC, Schutt AD, Holly M, Slice LW, Sherman MI, Richman DD, Potash MJ, Volsky DJ (1991) Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. Science 254: 1799–1802PubMedGoogle Scholar
  15. 15.
    Kinter AL, Poli G, Maury W, Folks TM, Fauci AS (1990) Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol 64: 4306–4312PubMedGoogle Scholar
  16. 16.
    Kretz-Remy C, Arrigo AP (1994) The kinetics of HIV-1 long terminal repeat transcriptional activation resemble those of hsp 70 promotor in heat-shock treated Hela cells. FEBS Lett 351: 191–196PubMedGoogle Scholar
  17. 17.
    La Thangue NB, Shriver K, Dawson C, Chan WL (1984) Herpes simplex virus infection causes the accumulation of a heat shock protein. EMBO J 3: 267–277PubMedGoogle Scholar
  18. 18.
    Luznik L, Kraus G, Guatelli J, Richman D, Wong-Staal F (1995) Tat independent replication of human immunodeficiency viruses. J Clin Invest 95: 328–332PubMedGoogle Scholar
  19. 19.
    Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, De Clercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20: 309–321PubMedGoogle Scholar
  20. 20.
    Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS (1990) Tumor necrosis factor-α functions in a autocirine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 87: 782–785PubMedGoogle Scholar
  21. 21.
    Re MC, Furlini G, Placa ML (1989) Rapid detection of HIV-1 in clinical samples by co-culture with heat-shocked cells. J Virol Methods 26: 313–318PubMedGoogle Scholar
  22. 22.
    Schlesinger MJ (1989) Heat shock proteins: the search for functions. J Cell Biol 103: 321–325Google Scholar
  23. 23.
    Stanley SK, Bressler PB, Poli G, Fauci AS (1990) Heat shock induction of HIV production from chronically infected promonocytic and T cell lines. J Virol 145: 1120–1126Google Scholar
  24. 24.
    Stanley SK, Folks TM, Fauci AS (1989) Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. AIDS Res Hum Retroviruses 5: 375–384PubMedGoogle Scholar
  25. 25.
    Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA (1988) In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity J Virol 62: 139–147PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • K. Hashimoto
    • 1
  • M. Baba
    • 2
  • K. Gohnai
    • 3
  • M. Sato
    • 1
  • S. Shigeta
    • 1
  1. 1.Department of MicrobiologyFukushima Medical CollegeFukushimaJapan
  2. 2.Division of Human Retroviruses, Center for Chronic Viral Diseases, Faculty of MedicineKagoshima UniversityKagoshimaJapan
  3. 3.Roku-chome ClinicSendaiJapan

Personalised recommendations